IRIS - Res&Arch Institutional Research Information System - Research & Archive

PARNETTI, Lucilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.497
EU - Europa 6.671
AS - Asia 2.763
AF - Africa 17
OC - Oceania 16
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 11
Totale 18.990
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.476
IE - Irlanda 1.737
UA - Ucraina 1.406
IT - Italia 1.117
SG - Singapore 1.027
SE - Svezia 704
HK - Hong Kong 703
VN - Vietnam 479
FI - Finlandia 391
DE - Germania 385
CN - Cina 353
RU - Federazione Russa 316
FR - Francia 149
GB - Regno Unito 120
RO - Romania 74
TR - Turchia 64
KR - Corea 63
CH - Svizzera 55
AT - Austria 39
NL - Olanda 37
BE - Belgio 34
CZ - Repubblica Ceca 34
UZ - Uzbekistan 22
GR - Grecia 21
PL - Polonia 21
EG - Egitto 17
CA - Canada 13
BR - Brasile 11
ES - Italia 11
EU - Europa 11
JP - Giappone 11
LB - Libano 11
NZ - Nuova Zelanda 10
IR - Iran 8
MX - Messico 7
AM - Armenia 6
AU - Australia 6
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
TW - Taiwan 3
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
LT - Lituania 2
NO - Norvegia 2
RS - Serbia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
IN - India 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PT - Portogallo 1
SA - Arabia Saudita 1
SV - El Salvador 1
TH - Thailandia 1
Totale 18.990
Salva come PNG Salva come JPEG
Città #
Chandler 1.966
Dublin 1.736
San Mateo 850
Singapore 777
Jacksonville 745
Hong Kong 694
Boardman 682
Dong Ket 479
Altamura 474
Santa Clara 473
Medford 405
Princeton 402
Wilmington 357
Lawrence 355
Perugia 291
Ann Arbor 259
Des Moines 247
Andover 184
Beijing 156
Saint Petersburg 121
Ashburn 115
San Paolo di Civitate 94
Falls Church 93
Helsinki 93
Los Angeles 78
Norwalk 73
Woodbridge 66
Seoul 60
Izmir 58
Redmond 54
Timisoara 35
Brussels 34
Bucharest 34
Rome 31
Munich 30
Dallas 29
Redwood City 27
New York 25
Houston 24
Moscow 22
Shanghai 21
Den Haag 20
Lausanne 19
Auburn Hills 17
Fairfield 17
Frankfurt Am Main 14
Lappeenranta 14
Brno 13
Paris 11
Saint Louis 11
Giza 10
Amsterdam 9
Bologna 9
Milan 9
San Diego 9
Tappahannock 9
Chicago 8
Florence 8
Olomouc 8
Tokyo 8
Auckland 7
Seattle 7
Ardabil 6
Madrid 6
Monmouth Junction 6
Toronto 6
Fremont 5
Mcallen 5
Turin 5
Yerevan 5
Adelaide 4
Cava de' Tirreni 4
Guangzhou 4
Hanover 4
Istanbul 4
Naples 4
Ottawa 4
Philadelphia 4
Terni 4
Al Mansurah 3
Bratislava 3
Brescia 3
Cambridge 3
Clifton 3
Duino-Aurisina 3
Edinburgh 3
El Paso 3
Frankfurt am Main 3
Harbin 3
Kiev 3
Lissone 3
Palermo 3
Radeberg 3
San Juan 3
Saronno 3
Sesto Fiorentino 3
Vienna 3
Zhengzhou 3
Alviano 2
Aprilia 2
Totale 13.127
Salva come PNG Salva come JPEG
Nome #
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 119
CSF and blood biomarkers for Parkinson's disease 118
A new assay for antiphospholipid antibodies in patient with ischemic stroke 115
Platelet MAO-B activity and vitamin B12 in old age dementias. 103
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 99
102.Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. 97
First-ever stroke and outcome in patients admitted to Perugia Stroke Unit:predictors for death, dependency, and recurrence of stroke within the first three months. 95
a-D-Mannosidses in patients with familial Alzheimer's Disease 94
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 93
a-D-Mannosidases in patients with Alzheimer's disease 90
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 90
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 88
Swalloving dysfunction: neurovascolar- anatomical correlation. 86
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 83
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 81
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry 80
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 79
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 77
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 77
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. 77
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 77
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 76
Cerebrospinal fluid biomarkers in Parkinson disease. 75
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 74
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 74
Vascular cognitive impairment: a pragmatic concept 74
Cerebrospinal fluid biomarkers and white matter lesions: can we know more? 74
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 74
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. 73
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 73
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 73
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 73
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 73
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 72
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 72
Early admission to stroke unit influences clinical outcome 72
Blood pressure and functional aspects of the aging brain. 72
The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration. 72
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 72
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 71
Brain SPECT in the diagnosis of degenerative dementia. 70
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 70
Association between migraine and headache attributed to stroke: a case-control study. 70
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 70
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 70
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 70
99mTc-HMPAO cerebral SPECT in cerebrovascular disease with and without dementia. 69
B-mode imaging and histomorphometric evaluation of carotid atherosclerosis. 69
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. 69
Hippocampal epileptogenesis in autoimmune encephalitis 69
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 69
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 68
Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. 67
Brain SPECT in pathological aging brain: Lewy Body Disease and Age-Associated Memory Impairment. 67
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 67
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 66
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 66
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 66
Acetyl-L-carnitine in the treatment of mildly demented elderly patients. 66
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. 66
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 65
Posatirelin for the treatment of late-onset Alzheimer's disease: a double-blind multicentre study vs citicoline and ascorbic acid. 65
Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study. 65
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 65
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 65
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 65
Lysosomal enzymes in Parkinson's disease 64
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 64
Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease. 63
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 63
White matter changes in stroke patients. Relationship with stroke subtype and outcome. 62
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 62
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 62
Activation of complement and contact system in Alzheimer’s disease 62
Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment. 62
Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. 62
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 62
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 61
Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients. 61
Carotid atherosclerotic disease: role of hypertension and other risk factors. 61
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 61
[Drinking-water and cardiovascular mortality]. 60
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 60
A magnetization transfer study of mild and advanced Parkinson's disease. 60
Is multi-infarct dementia representative of vascular dementias? A retrospective study 59
Brain SPECT in different dementia disorders: AD, Possible AD, Preclinical AD, AAMI, FTD, LBD, VaD, secondary dementia. 59
Arterial hypertension and stroke prevention: an update. 59
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type. 59
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 58
Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia. 58
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 58
Le emozioni nei contesti individuali e sociali 58
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 58
Atrial fibrillation and stroke. 57
Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group. 57
Pathogenetic mechanisms in vascular dementia. 57
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 57
Lysosomial hydrolase in cerebrospinal fluid from subjects with Parkinson's disease 56
Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers. 56
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 56
Totale 7.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.132 0 0 0 0 199 12 239 35 281 139 77 150
2020/20213.135 16 204 90 217 989 137 202 39 340 123 240 538
2021/20223.192 80 580 88 141 96 85 53 944 100 131 372 522
2022/20236.532 437 1.297 81 564 491 799 15 271 2.295 18 197 67
2023/20242.424 184 280 126 59 27 14 463 97 273 99 397 405
2024/20251.921 86 606 234 283 712 0 0 0 0 0 0 0
Totale 19.825